McKesson Corp (MCK)

$552.15 8.75 (1.56%)

19:00 EDT MCK Stock Quote Delayed 30 Minutes

Earnings Visibility Metrics Restrict McKesson (MCK) Ratings Upgrade to Hold

By Portfolio Grader Nov 22, 2017

McKesson Corp (NYSE:MCK) is classified as a component of the 82 company Health Care Providers & Services GICS industry group, which is part of the 781 company GICS Health Care sector. MCK's market value is $29.6 billion which places it in the top decile in its industry group. The ranking for MCK by Portfolio Grader places it 48 among the 82 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 424 among the 781 companies in the sector, and number 2,720 in the nearly 5,000 company Portfolio Grader universe.

Deleterious Quant Score Drop McKesson (MCK) to Sell

Earnings Visibility Keep McKesson (MCK) a Sell

Industry Group Rank Metrics Keep McKesson (MCK) Upgrade to Hold

Volume:

Previous Close -

Market Cap 85.40B

PE Ratio 24.72

EPS 22.34

Volume (Avg. Vol.) 710,193

Day's Range $551.02 - $562.50

52-Week Range $404.72 - $637.51

Dividend & Yield $2.48 (0.45%)

MCK Stock Predictions, Articles, and McKesson Corp News

Shrinking Industry Group Rank Keeps McKesson (MCK) a Sell

By Portfolio Grader Oct 25, 2017

Currently, McKesson Corp (NYSE:MCK) has a Sell using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking MCK has had from Portfolio Grader for 7 months.

Shrinking Earnings Visibility Keeps McKesson (MCK) a Sell

By Portfolio Grader Oct 18, 2017

Portfolio Grader currently ranks McKesson Corp (NYSE:MCK) a Sell. With unique fundamental and quantitative metrics developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. MCK has maintained this ranking for 7 months.

Sell Rating for McKesson (MCK) Shares Maintained

By Portfolio Grader Oct 11, 2017

Portfolio Grader currently ranks McKesson Corp (NYSE:MCK) a Sell. The methods for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for 6 months.

Sell Rating for McKesson (MCK) Shares Maintained

By Portfolio Grader Oct 4, 2017

Hershey Co (HSY) Leads 8 Dividend Increases This Week

By Brian Bollinger, Simply Safe Dividends Jul 28, 2017

Eight notable dividend stocks recently raised their payouts, including Hershey (HSY) and McKesson (MCK). Here's what you need to know.

Rite Aid Corporation (RAD) Stock Will Disappear. The End Is Near.

By Will Ashworth, InvestorPlace Contributor Jun 27, 2017

If Walgreens can't buy Rite Aid, there's not much hope for shareholders going forward. Here are three merger-less scenarios for RAD stock.

McKesson Corporation (MCK) Shares Fly on Earnings Beat, Upbeat Forecast

By William White, InvestorPlace Writer May 19, 2017

McKesson (MCK) stock was sitting pretty on Friday following the release of its earnings report for its fiscal fourth quarter of 2017.

3 Big Stock Charts for Friday: Alibaba Group Holding Ltd (BABA), McKesson Corporation (MCK) and Analog Devices, Inc. (ADI)

By Johnson Research Group May 19, 2017

Alibaba (BABA), Analog Devices (ADI) and McKesson (MCK) are rally bound on recent earnings results and drops in their stock prices this week.

Valeant Pharmaceuticals Intl Inc (VRX) Stock Could More Than Double

By Ryan Fuhrmann, InvestorPlace Contributor May 3, 2017

Valeant Pharmaceuticals believes it stabilized its business and will be in turnaround mode for years. For once, VRX stock deserves optimism.

The 10 Biggest Companies You’ve Never Heard Of

By Vince Martin, InvestorPlace Contributor Jan 11, 2017

Many of the country's largest businesses operate outside of public view. Here are 10 of the largest companies unfamiliar to most Americans.

10 Health Care Providers & Services Stocks to Sell Now

By Portfolio Grader Dec 20, 2016

This week, 10 Health Care Providers & Services stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

10 Health Care Providers & Services Stocks to Sell Now

By Portfolio Grader Nov 22, 2016

This week, the ratings of 10 Health Care Providers & Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Beaten-Down Healthcare Stocks to Buy

By Ryan Fuhrmann, InvestorPlace Contributor Nov 2, 2016

Allergan (AGN), Zimmer Biomet (ZBH) and McKesson (MCK) are three bona fide leaders in their respective healthcare industries.

10 Health Care Providers & Services Stocks to Sell Now

By Portfolio Grader Nov 1, 2016

The ratings of 10 Health Care Providers & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").